Articles On PainChek (ASX:PCK)

Title Source Codes Date
What the heck is going on with the PainChek (ASX:PCK) share price?

PainChek Ltd (ASX: PCK) has been dealt a speeding ticket today following its share price and trading volume taking off over the past few days. The company’s stock finished last Thursday’s session trading at 4.5 cents. Since then, it has su...

Motley Fool PCK 1 week ago
Webinar on Healthcare Innovations for Sustainable Future by Kalkine Media on October 21, 2021

SYDNEY, Oct. 16, 2021 /PRNewswire/ — Ensuring healthy lives and promoting physical and mental well-being is essential to sustainable development. Currently, the world is facing a global health crisis unlike any other. Global health has i...

FNArena PCK 1 month ago
Market Highlights and 5 ASX Small Caps to watch on Monday

S&P 500 closed at record high again Wall Street closed Friday mostly on a high note, with the S&P 500 once again reaching an all-time high. The S&P 500 climbed by 0.33%, the Dow Jones rose by 0.69%, but tech heavy Nasdaq fell sl...

Stockhead PCK 5 months ago
Last Orders: Another big gain in energy shares leads the ASX to a positive closing

A big surge in energy shares led the ASX into positive territory for the second day in a row. The ASX 200 closed 0.59 per cent higher at 7,260 points although the ASX Emerging Companies Index closed 0.28 per cent lower at 2,188. Energy led...

Stockhead PCK 6 months ago
ASX 200 today: Will Australian shares continue their record run?

Summary Day after scaling a record high level, the ASX 200 on Thursday again opened higher. The investors were upbeat on strong GDP data. On Wednesday, the benchmark Australian index ended 1.05% higher at 7,217.80. The Australian...

Kalkine Media PCK 6 months ago
PainChek expands into infant market, with ambitions to scale globally

There are 50 million people living with dementia and 400 million pre-verbal children, at any given point in time. Despite being in the opposite stages of life, both groups actually have something in common – they have difficulty in reliably...

Stockhead PCK 6 months ago
ScoPo’s Powerplays: Hearing tech, medical devices to ride out choppy market

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Stockhead PCK 6 months ago
The PainChek (ASX:PCK) share price is rising on its latest announcement

Shares in PainChek Ltd (ASX: PCK) are gaining today after news the company has received regulatory clearances for its app, PainChek Infant. At the time of writing, the PainChek share price is up 6.15%, with shares in the company swapping h...

Motley Fool PCK 6 months ago
Three ASX healthcare shares on the rise today – AHI, PCK, 4DX

Summary Advanced Human Imaging has entered into a binding agreement with Jana Care to bring affordable digitally connected care to everyone. PainChek Infant has obtained the necessary regulatory approvals in multiple International mark...

Kalkine Media PCK 6 months ago
Advanced Human Imaging and PainChek gain after taking their next steps internationally

It was a good morning for shareholders of PainChek (ASX:PCK) and Advanced Human Imaging (ASX:AHI), a pair of companies using smartphone technology to detect ailments. The companies, aspiring to go global, informed shareholders of major deve...

Stockhead PCK 6 months ago
Market highlights and 5 ASX small caps to watch on Thursday

Wall Street slips for third consecutive day Inflation worries have persisted in the market, with all major indices in the US falling again overnight, bringing the string of losses to three consecutive days. The Dow Jones was down 0.48%, S&a...

Stockhead PCK 6 months ago
Here are the ASX aged care stocks that rose after the $17bn budget windfall

There were only nice surprises in the aged-care funding announced by the Treasurer last night, with the government seemingly set to overhaul the sector with a $17.7 billion cash-splash over the next five years. Roughly a third of that will...

Stockhead PCK 6 months ago
Telemedicine witnesses a boom amid COVID-19: A look at 3 ASX stocks  

Summary With the current emergency, it is anticipated that telehealth or telemedicine could be the future of medicine. COVID-19 pandemic resulted in considerable adoption of telehealth solutions, mainly to avoid physical contact. The...

Kalkine Media PCK 7 months ago
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Stockhead PCK 8 months ago
Why the Painchek (ASX:PCK) share price is charging 13% higher

The PainChek Ltd (ASX: PCK) share price is soaring today after the company announced it has received approvals for its latest pain monitoring app update. At the time of writing, the mobile medical app developer’s shares are up 13% to 7.8 c...

Motley Fool PCK 8 months ago
Here’s why PainChek (ASX:PCK) share price is up nearly 12% today

Source:MonsterStudio,Shutterstock Summary Mobile-based healthcare technology developer PainChek has obtained CE Mark and TGA approval for its Universal app. PainChek to launch its Universal app across Australia and the UK from April 2...

Kalkine Media PCK 8 months ago
PainChek’s ‘universal’ pain-detecting app approved in Europe, Australia

PainChek (ASX:PCK) says it has received regulatory approval to market the next generation of its pain-detecting smartphone app in Europe, the United Kingdom and Australia. The company has received CE Mark clearance in Europe and Therapeutic...

Stockhead PCK 8 months ago
Market highlights and 5 ASX small caps to watch on Wednesday

Wall Street pulls back Blue chip Dow Jones finally had an off-day, falling by 0.39% after reaching consecutive record highs in the last few days. S&P 500 also fell by 0.16%, while tech heavy NASDAQ rose slightly by 0.09%. The major tech...

Stockhead PCK 8 months ago
Philip Daffas from Painchek (ASX:PCK)

Peter Switzer is joined by Philip Daffas, the CEO and Managing Director of Painchek (PCK).

Switzer PCK 8 months ago
Hidden Gems Webinar Recap – PCK, CV1, GLN, CE1 – 26/2/21

ShareCafeHidden Gems Webinar Recap – PCK, CV1, GLN, CE1 – 26/2/21 Catch up on the full webinar with presentations from Painchek (ASX:PCK), CV Check (ASX:CV1), Galan Lithium (ASX:GLN), Calima Energy (ASX:CE1) Hidden Gems Webinar Recap – PCK...

ShareCafe PCK 9 months ago
PainChek (ASX:PCK) – Hidden Gems Webinar Presentation

ShareCafePainChek (ASX:PCK) – Hidden Gems Webinar Presentation Presenter – Philip Daffas – CEO & Director – PainChek is transforming pain management to help give a voice to those who cannot verbalise their pain. PainChek uses facial re...

ShareCafe PCK 9 months ago
Why the Painchek (ASX:PCK) share price is edging higher today

The PainChek Ltd (ASX: PCK) share price was among the few ASX shares that stayed in the green today, closing up 2.56% at 8 cents. The share price increase came off the back of the company half-year report announced to the market yesterday....

Motley Fool PCK 9 months ago
One year on and 50% up, the All Technology Index is booming

Next week marks one year since the S&P/ASX All Technology Index (ASX: XTX) debuted. Launched at the end of February 2020, the All Technology Index debuted just in time for the March market meltdown. The index saw its value tumble 42%...

Motley Fool PCK 9 months ago
Why the Painchek (ASX:PCK) share price lifted today

The Painchek Ltd (ASX: PCK) share price climbed today after the company provided the market with a positive quarterly update for December 2020. Shares in the small cap healthcare company were trading 4.2% higher at 7.4 cents on close of tr...

Motley Fool PCK 10 months ago
Here’s why PainChek (ASX:PCK) shares are up ~6% today

Summary PainChek® has completed PainChek Infant Face-Only clinical trial to support regulatory clearance in Australia and Europe. PainChek delivers on sales growth during aged care lock-down while continuing market expansion. In Decem...

Kalkine Media PCK 10 months ago
PainChek (ASX:PCK) share price lower despite Ramsay (ASX:RHC) partnership

The PainChek Ltd (ASX: PCK) share price is dropping lower on Friday morning following the release of an announcement. In morning trade the healthcare technology company’s shares are down 3% to 9.2 cents. What did PainChek announce? Investo...

Motley Fool PCK 1 year ago
Health Kick Podcast: PainChek’s AI-backed pain assessment tech a game-changer for treating infants and the elderly

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up the microphone for another instalment ... Read More The post Health Kick Podcast: PainChek’s AI-backed pain assessment tech a game-changer for...

Stockhead PCK 1 year ago
August In Review: Technology Powers On

The ASX200 rose 2.2% in August with technology and consumer discretionary leading the way during the reporting season, while further trading updates are expected during the upcoming AGM season. –The ASX200 climbed 2.2% during August, gainin...

FNArena PCK 1 year ago
PainChek – ShareCafe Hidden Gems Webinar Presentation

ShareCafePainChek – ShareCafe Hidden Gems Webinar Presentation   Presenter – Philip Daffas – CEO & MD – PainChek® is the world’s first pain assessment tool that has regulatory clearance in Australia and Europe. Using AI and facial reco...

ShareCafe PCK 1 year ago
Hidden Gems Webinar Recap – PCK, WOA, PYG, AJQ

ShareCafeHidden Gems Webinar Recap – PCK, WOA, PYG, AJQ   We continue to unearth small-cap companies as part of our Hidden Gems webinar series. Catch up on the full webinar with presentations from PainChek (ASX: PCK), Wide Open Agriculture...

ShareCafe PCK 1 year ago
Mobile medical device biz PainChek taps Bells, Canaccord for raising

Mobile medical device outfit PainChek was out hunting for fresh capital on Friday to finance taking its adult dementia mobile application overseas.

AFR PCK 1 year ago
Large caps deny they’re being outgunned by smaller peers in health R&D

The journey of each individual medical treatment from idea to market requires the involvement of multiple parties big and small. The general consensus seems to be that it takes a big player to get a drug to market, which more often than not...

Stockhead PCK 1 year ago
Small but mighty: The ASX health small caps aiming to beat the government in the innovation game

Almost all of the ASX’s health small caps have visions as ambitious as the Australian and state governments’ broader health objectives for society as a whole. The combined market caps of all ASX health companies under $500m is approximately...

Stockhead PCK 1 year ago
Flying or Falling: Are 2019’s top 5 health stocks still racing ahead this year?

Last year was a solid year for many ASX stocks and 2020 was also looking pretty good until COVID-19 struck the markets in late February. Earlier this week Reuben Adams recapped which of last year’s top mining and exploration companies have...

Stockhead PCK 1 year ago
Check up: Health stocks firing on excitement… and little else

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks and of those which were trading on Tuesday, 59 were in positive territory over the last fortnight, 22 were flat and 58 saw t...

Stockhead PCK 1 year ago
PainChek (ASX:PCK) patent

08 May 2020 - PainChek® (ASX:PCK) has received a notice of allowance from the Australian Patent Office for its pain assessment invention.

FNN PCK 1 year ago
Quarterlies: Here are 5 of the best quarterlies released on the ASX this morning

Today Stockhead has gone through the best and worst 4C releases so you don’t have to. And tech companies were among the standouts today.   CV Check (ASX:CV1) As its name suggests, this company’s bread and butter is checking CVs. It surpasse...

Stockhead PCK 1 year ago
Residential aged care sector drives strong quarterly results for PainChek

Australian medical device company PainChek (ASX: PCK) has reported a strong performance for the March quarter with much of its growth being driven by the country’s residential aged care sector. PainChek’s smartphone-based pain assessment te...

SmallCaps PCK 1 year ago
PainChek Share Price Up 13% As Healthcare Sector Soars

Mobile medical app developer Painchek Ltd [ASX:PCK] has seen its share price jump 13.24% today, up 0.9 cents to trade at 7.7 cents per share. The post PainChek Share Price Up 13% As Healthcare Sector Soars appeared first on Money Morning Au...

MoneyMorning PCK 1 year ago
PainChek grows number of licenced beds, triggers $1.25 million payment from Federal Government

Medical device company PainChek (ASX: PCK) confirmed it has met an important 25,000 licenced bed milestone under a $5 million grant agreement with the Australian Federal Government. In total, PainChek achieved more than 44,000 licenced beds...

SmallCaps PCK 1 year ago
Dementia sufferers in Australia will hit 1 million, can these small caps come up with a treatment?

Dementia already affects hundreds of thousands of people in Australia, and it’s only going to get worse if a medical miracle is not forthcoming. The term relates to brain diseases, including Alzheimers, that impact a person’s ability to thi...

Stockhead PCK 1 year ago
Australian Broker Call *Extra* Edition – Feb 10, 2020

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

FNArena PCK 1 year ago
PainChek secures Japanese patent and progresses expansion

Australian company PainChek (ASX:PCK) says it been granted a patent in Japan for its smartphone pain assessment and monitoring technology.

BiotechDispatch PCK 1 year ago
Health: Alterity gets orphan status for its MSA drug

The European Commission has granted Orphan drug status for Alterity Therapeutics’ (ASX:ATH) lead molecule, PBT434, for the treatment of Multiple System Atrophy (MSA). That gives Alterity 10 years of market exclusivity in the European Union...

Stockhead PCK 1 year ago
Health: PainChek reveals exactly how much its grown in 2019; and says there’s more to come next year

It’s fair to assume PainChek (ASX:PCK) shareholders are a happy bunch with a 12-month share price rise of 413 per cent. The rise of the pain-detection app company began in late April thanks to a $5m investment from the Morrison government....

Stockhead PCK 1 year ago
On the Radar: 5 small caps that brokers pick for growth in the months ahead

As the year winds down and AGM season concludes brokers have been busy filling their Christmas stockings with stock picks they think will be winners. Here are five predictions made in the last week that stood out: 1. Navarre Minerals (ASX:N...

Stockhead PCK 2 years ago
PainChek expands UK presence with first orders of pain assessment technology

Australian medical device company PainChek (ASX: PCK) is expanding its presence in the UK market, making its first direct sale and confirming first orders for the region. PainChek has developed a smartphone-based medical device using artifi...

SmallCaps PCK 2 years ago
PainCheck Expands Presence in UK Market

PainChek Limited (ASX: PCK) has received first 1,000 PainChek annual bed license order from Person Centred Software UK (PCS UK). The collaboration with PCS provides immediate access to 1500 homes but more crucially, a significantly higher p...

Kalkine Media PCK 2 years ago
Short and Caught: The ASX stocks investors are shorting right now

Short & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorted. Stocks that are shorted have investors betting that they fall. Shorting works by selling stocks you do not actually own in the hope of bu...

Stockhead PCK 2 years ago
Dr Boreham’s Crucible: Uscom gets an A for everything but its share price

We hate to sound like an old school report, but it’s been a year of steady and solid progress for the maker of non-invasive cardiac and pulmonary measuring devices, especially in its key target market of China. Achievements include record r...

Stockhead PCK 2 years ago